from Greek; muscle, and Tonus
from Latin; tension) is a symptom of a small handful of certain neuromuscular
disorders characterized by delayed relaxation (prolonged contraction) of the skeletal muscles
after voluntary contraction or electrical stimulation.
Myotonia is present in Myotonia congenita
, Paramyotonia Congenita
and myotonic dystrophy
Generally, repeated contraction of the muscle can alleviate the myotonia and relax the muscles thus improving the condition, however this is not the case in Paramyotonia congenita
. This phenomenon is known as "Warm-Up" and is not to be confused with warming up before exercise, though they may appear similar. Individuals with the disorder may have trouble releasing their grip on objects or may have difficulty rising from a sitting position and a stiff, awkward gait.
Myotonia can affect all muscle groups; however, the pattern of affected muscles can vary depending on the specific disorder involved.
People suffering from disorders involving myotonia can have a life-threatening reaction to certain anaesthetics
; one of these conditions occurs when the patient is under anaesthetic and is termed " Malignant hyperthermia
Myotonia may present in the following diseases with different causes related to the ion channels in the skeletal muscle fiber membrane ( Sarcolemma
Two documented types, DM1 and DM2 exist. In myotonic dystrophy a nucleotide expansion of either of two genes, related to type of disease, results in failure of correct expression (splicing of the mRNA) of the ClC-1 ion channel, due to accumulation of RNA in the cytosol of the cell. The ClC-1 ion channel is responsible for the major part of chloride conductance in the skeletal muscle cell, and lack of sufficient chloride conductance may result in myotonia, (see myotonia congenita
). When the splicing of the mRNA was corrected in vitro, ClC-1 channel function was greatly improved and myotonia was abolished.
(Congenital Myotonia) of which two types called Becker's Disease and Thomsen's Disease exist. Both diseases are caused by mutations in the gene CLCN1
encoding the ClC-1 ion channel. More than 130 different mutations exist in total, and a large phenotypic variation is therefore present in this disease. The mutations are loss-of-function mutations that render the ClC-1 ion channel dysfunctional to varying degrees, with reduced chloride conductance as a result. Reduced chloride conductance may result in myotonia, due to accumulation of potassium in the transverse-tubules in skeletal muscle (see myotonia congenita
Symptoms of myotonia (documented in myotonia conganita) are more frequently experienced in women during pregnancy.
This disease results from mutation in the gene encoding the voltage-gated sodium channel
Nav1.4 in skeletal muscle fiber membrane. Mutations may alter the kinetics of the channel, such that the channel fails to inactivate properly, thus allowing spontaneous action potential
s to occur after voluntary activity has terminated, prolonging relaxation of the muscle, or can result in paralysis if the relaxation is severely prolonged (see SCN4A